AI in Pharma: Accelerating Drug Development and Personalizing Healthcare
Abstract
Artificial Intelligence (AI) and machine learning are useful in drug discovery, pharmaceutical formulation and dosage form testing. By analyzing biological data like preteomics and genomics. Researchers can indentify disease related target and predicts how they will interact with treatment. AI is rapidly becoming a powerful tool that help solve complex problems more quickly and efficiently. This improve drug approval success and helps focus drug research efforts. AI also lower the process and expense of development. The pharmacokinetics and toxicity of possible drugs are predicted by machine learning algorithms, which also aid in study design. Artificial Intelligence ( AI ) systems evaluate real patients data and assists with medical plan to improve treatment results. AI and drug discovery have many uses including design, testing, and pharmacokinetics and pharmacodynamic analysis. The ongoing research into AI by the pharmaceutical industry today presents numerous chances to improve patient care and the medication development process.
References
2. Generating evidence for artificial intelligence-based medical devices: a framework for training, validation and evaluation. Geneva: World Health Organization; 2021
3. Savage N. News feature. Tapping into the drug discovery potential of AI. Nature, 27 May 2021
4. Bender A, Cortes-Ciriano I. Artificial intelligence in drug discovery: what is realistic, what are illusions.
5. Artificial intelligence and machine learning for drug development. Silver Spring(MD): Food and Drug Administration; 2023.
6. National Library of Medicine, National Center for Biotechnology Information.
7. Madura KPJ, Xie W, Ruder L, Schulze U, Meier C. AI in small-molecule drug discovery: a coming wave
8. Unlocking the potential of AI in drug discovery. London: Welcome Trust; 2023.
9. Miseta E. DiMe reports significant growth in digital endpoints. Clinical Leader, 9 December 2021.
10. Artificial intelligence for drug discovery. Landscape overview Q3 2022. London: Deep Pharma Intelligence; 2022.
11. Furlong A. Regulating the machine: Europe race to get to grips with AI drugs. Politico, 7 April 2023.
12. Mohs RC, Greig NH. Drug discovery and development: Role of basic biological research. Alzheimer Dement (N Y). 2017.
13. Wang H, Fu T, Du Y, Gao W, Huang K, Liu Z et al. Scientific discovery in the age of artificial intelligence. Nature 2023.
14. Dill KA, Ozkan SB, Shell MS, Weikl TR. The protein folding problem. Annu Rev Biophys.
15. Metz C. London AI lab claims breakthrough that could accelerate drug discovery. The New York Times.
16. Heaven WD. AI for protein folding. MIT Technology Review, 23 February 2022
17. AlphaFold protein structure database. Hinxton: EMBL-EBI; 2023.
18. Nolan A. Artificial intelligence and the future of science. Paris: Organisation for Economic Co-operation and Development; 2021.
19. Kollewe, Julia, Drug companies look to end “hit and miss” research. The Guardian, 20 February 2021.
20. Pun FW, Ozerov IV, Zhavoronkov A. AI-powered therapeutic target discovery. Trends Pharmacol Sci. 2023.
